VivaCell-MTS boosts development of neonatal health care in Armenia

VivaCell-MTS boosts development of neonatal health care in Armenia

PanARMENIAN.Net - VivaCell-MTS and BirthLink have been cooperating for already 8 years now, aiming to reduce neonatal mortality and morbidity by supporting the care of sick and premature babies in Armenia. Since the start of the project, VivaCell-MTS has allocated some AMD 600 million to equip forty-three hospitals in Yerevan and the provinces.

Following the 2000 Millennium Development Goal to reduce child mortality by 2015, WHO states there is an unfinished agenda for Women and Children’s health, with newborn deaths still accounting for 44% of under-five deaths globally. Cost-effective solutions are now available to protect women and children on the day of birth: 80% of newborn deaths are caused by preventable and treatable conditions.

VivaCell-MTS will host neonatologists from maternity hospitals of the provinces and Yerevan for two days, who will be trained to achieve quality improvement, national standards of care. At the seminar, a new Neonatal Database program that enables monitoring all babies requiring intensive care after birth will be introduced.

VivaCell-MTS General Manager Ralph Yirikian, the Chief Neonatologist of Armenia Pavel Mazmanyan and the Director of BirthLink Kathy Mellor welcomed the neonatologists at the beginning of the seminar.

 Top stories
RSF said media diversity has blossomed but the government has failed to reduce the media’s polarization.
Caoili got into a car accident on March 14 and underwent several surgeries before being taken back to the intensive care unit.
The first case is a woman who arrived from Italy amid the raging pandemic and attended a crowded engagement party.
Austria is among the 16 countries whose citizens can't visit Armenia, according to a decision by the Commandant's Office.
Partner news